Patent Owner Prevails In Final Written Decision By Patent Board

(January 11, 2018, 4:32 PM EST) -- ALEXANDRIA, Va. — A patent relating to Novartis AG’s Afinitor anti-cancer drug was confirmed as patentable Jan. 11 in a final written decision by the Patent Trial and Appeal Board, which...
To view the full article, register now.